Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.AEZS
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:AEZS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(13)
•••
jrsloan60
X
View Profile
View Bullboard History
Post by
jrsloan60
on Jul 19, 2024 2:49pm
Now I know why he moved to the NASDAQ
It trades 400% more on the NASDAQ. It's just about 500 shares. It's sold today. 400% better than on the been on venture.
(13)
•••
jrsloan60
X
View Profile
View Bullboard History
Post by
jrsloan60
on Jul 19, 2024 2:47pm
Quick question
Why does it seem nobody wants the shares. Trades a hundred shares a day. Did our CEO get the market angry at him?
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 19, 2024 2:01pm
Avenanthramide pill
2023 AGM: CZO will be testing 100X higher dosing than in the exercise inflammation study. Based on the human exercise inflammation study at the University of Minnisota CZO is confident in a very
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 19, 2024 1:57pm
Wound healing franchise
2023 AGM: "Very, very successful study..." Will look at a franchinse in wound healing given results from McMaster and from the Angogenesis Foundation.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jul 18, 2024 10:05am
RE:On the launch pad...
It is also one year today since the new Angiogenesis Foundation study was announced for wound healing. Gilles called the previous results a "home run" and has talked about a potential wound
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 18, 2024 9:52am
On the launch pad...
Merger closed. Board of Directors approved. New company name approved. New stock symbol, branding, and website incoming. 1) Diagnostic: Last patient last visit for the pediatric diagnostic trial
...more
(109)
•••
fossi_2002
X
View Profile
View Bullboard History
Post by
fossi_2002
on Jul 17, 2024 10:08am
Gilles Gagnon - chief officer without a majority
Unfortunately, my broker/bank had great difficulty transferring Ceapro to Aeterna due to the small remaining shares. This meant that it was not possible to take part in the AGM vote. With the votes of
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 17, 2024 6:42am
AGM: A stunning silence
Compared to last year a stunnng silence at this year's AGM. Nothing. Here's a reminder of last year's AGM. Numerous events appear potentially imminent or very close at hand. Post
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jul 16, 2024 5:49pm
RE:RE:Still in silent mode...
Only about 790,000 shares voted. Didn't take many shares to put someone over the top in the context of outstanding shares. By next year the shareholder base/voting base could be very different
...more
(2119)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jul 16, 2024 5:44pm
RE:New Press Release - Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders
48.82% no votes for Gagnon. I want a recount.
(2011)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Jul 16, 2024 4:27pm
RE:RE:New Press Release - Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders
My error, technically one had to be owners of shares with a record date of June 14th to vote, so the runup was for another reason as others thought, just to buy YES votes based on short term share
...more
(2011)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Jul 16, 2024 4:23pm
RE:New Press Release - Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders
Explanation for the recent runup in the share price. They can see the votes in advance of the AGM so it became clear that Gilles needed some help in the amount of about 20K shares. So just prior to
...more
(7)
•••
archeo753
X
View Profile
View Bullboard History
Comment by
archeo753
on Jul 16, 2024 4:19pm
RE:Still in silent mode...
Anyone know why Dennis Turpin got voted out? Looks like Ceapro board members were more popular than AEZS board members. Except for Gilles. The results of the vote in respect of the
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 16, 2024 4:05pm
New Press Release - Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders
TORONTO, ONTARIO, July 16, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for...
read article.
(2011)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Jul 16, 2024 3:04pm
RE:Merger Vote
I assume the grifting under a new name continues. For those who held onto their shares, best of luck.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden